Updated on 28 August 2026
Partnership offer with UL Faculty of Medicine and Life Sciences Department of Pharmaceutical Sciences
Research Manager at University of Latvia
Riga, Latvia
About
The Department of Pharmaceutical Sciences offers high-quality academic experience, combining innovative research with a strong commitment to interdisciplinary collaboration. We contribute to the university’s academic excellence by preparing knowledgeable and skilled professionals in the field of basic medical sciences, with a particular focus on pharmaceuticals.
We're offering deep scientific expertise in research area of Genetic and Epigenetic Biomarkers:
• Discovery and characterization of molecular markers for the prevention, progression, and treatment of human and animal diseases.
• Development of machine learning models for predicting autoimmune and neurodegenerative disease progression.
• Applications in practical genomics for animal and plant breeding, as well as personalized veterinary medicine.
Besides the deep scientific expertise in genetic and epigenetic Biomarkers, the head of department Tenured Professor, Dr. biol. Una Riekstiņa is deeply passionate about advancing research in precision medicine. Her work focuses on:
-
Cell-based therapeutics – Exploring induced pluripotent stem cells for tissue and organ regeneration, as well as investigating the pathogenesis of rare diseases.
-
Personalized medicine – Utilizing organ-on-a-chip technology to screen medicinal substances for tailored treatments.
-
Targeted therapy – Developing therapeutic agents, diagnostic biosensors, and tools using aptamer and nanomaterials technology.
We are always open to collaboration and innovative research opportunities in these fields. Let's connect!
Topic
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-08 Towards Artificial General Intelligence (AGI) for healthcare
Type
- Partner seeks Consortium/Coordinator
Similar opportunities
Project cooperation
The Centre for Innovative Medicine (IMC)
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
Tatjana Ivaskiene
General manager at State Research Institute Centre for Innovative Medicine
Vilnius, Lithuania
Project cooperation
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Roksana Zakharyan
Senior Researcher, Institute of Molecular Biology at Institute of Molecular Biology
Yerevan, Armenia
Project cooperation
The Centre for Innovative Medicine (IMC)
- Partner seeks Consortium/Coordinator
- Consortium/Coordinator seeks Partners
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
Tatjana Ivaskiene
General manager at State Research Institute Centre for Innovative Medicine
Vilnius, Lithuania